173 related articles for article (PubMed ID: 3149682)
21. [Perspectives on the development of a streptococcal vaccine].
Evseev VA
Zh Mikrobiol Epidemiol Immunobiol; 1976 Feb; (2):9-16. PubMed ID: 57684
[No Abstract] [Full Text] [Related]
22. New multi-determinant strategy for a group A streptococcal vaccine designed for the Australian Aboriginal population.
Brandt ER; Sriprakash KS; Hobb RI; Hayman WA; Zeng W; Batzloff MR; Jackson DC; Good MF
Nat Med; 2000 Apr; 6(4):455-9. PubMed ID: 10742155
[TBL] [Abstract][Full Text] [Related]
23. Group A streptococcal M proteins: virulence factors and protective antigens.
Robinson JH; Kehoe MA
Immunol Today; 1992 Sep; 13(9):362-7. PubMed ID: 1281632
[TBL] [Abstract][Full Text] [Related]
24. A new heart-cross-reactive antigen in Streptococcus pyogenes is not M protein.
Barnett LA; Cunningham MW
J Infect Dis; 1990 Oct; 162(4):875-82. PubMed ID: 1698206
[TBL] [Abstract][Full Text] [Related]
25. [Molecular structure and immunochemistry of streptococcal M-protein].
Ookuni H
Tanpakushitsu Kakusan Koso; 1990 Nov; 35(15):2839-51. PubMed ID: 1701908
[No Abstract] [Full Text] [Related]
26. Immunological crossreactivity between the class I epitope of streptococcal M protein and myosin.
Cunningham MW; Quinn A
Adv Exp Med Biol; 1997; 418():887-92. PubMed ID: 9331792
[No Abstract] [Full Text] [Related]
27. [A study on streptococcal prevalence in Chiang Mai, Thailand, with special reference to unusual combination between T and M antigens of group A Streptococcus].
Murai T; Inazumi Y; Pruksakorn S
Kansenshogaku Zasshi; 1988 Oct; 62(10):869-77. PubMed ID: 3145307
[No Abstract] [Full Text] [Related]
28. Streptococcal vaccines and global strategies for prevention of rheumatic fever.
Stollerman GH
Am J Med; 1980 May; 68(5):636-8. PubMed ID: 6990756
[No Abstract] [Full Text] [Related]
29. Type-specific antibodies to structurally defined fragments of streptococcal M proteins in patients with acute rheumatic fever.
Bisno AL; Berrios X; Quesney F; Monroe DM; Dale JB; Beachey EH
Infect Immun; 1982 Nov; 38(2):573-9. PubMed ID: 6754620
[TBL] [Abstract][Full Text] [Related]
30. Streptococcal defenses against host immune attack: the M protein-fibrinogen interaction.
Whitnack E; Dale JB; Beachey EH
Trans Assoc Am Physicians; 1983; 96():197-202. PubMed ID: 6208666
[No Abstract] [Full Text] [Related]
31. Intranasal immunisation of mice with a streptococcal peptide-based vaccine.
Relf W; Hayman W; Russell-Jones G; Good M
Adv Exp Med Biol; 1997; 418():859-61. PubMed ID: 9331788
[No Abstract] [Full Text] [Related]
32. Antigenic specificity of lymphocytes isolated from valvular specimens of rheumatic fever patients.
Yoshinaga M; Figueroa F; Wahid MR; Marcus RH; Suh E; Zabriskie JB
J Autoimmun; 1995 Aug; 8(4):601-13. PubMed ID: 7492353
[TBL] [Abstract][Full Text] [Related]
33. Group A streptococcus epidemiology and vaccine implications.
Cohen-Poradosu R; Kasper DL
Clin Infect Dis; 2007 Oct; 45(7):863-5. PubMed ID: 17806050
[No Abstract] [Full Text] [Related]
34. Strategic development of the conserved region of the M protein and other candidates as vaccines to prevent infection with group A streptococci.
Good MF; Pandey M; Batzloff MR; Tyrrell GJ
Expert Rev Vaccines; 2015; 14(11):1459-70. PubMed ID: 26485214
[TBL] [Abstract][Full Text] [Related]
35. Epitopes of group A streptococcal M protein shared with antigens of articular cartilage and synovium.
Baird RW; Bronze MS; Kraus W; Hill HR; Veasey LG; Dale JB
J Immunol; 1991 May; 146(9):3132-7. PubMed ID: 2016540
[TBL] [Abstract][Full Text] [Related]
36. [Further study of the prevention of streptococcal infections in experiments on monkeys].
Keller V; Dzhikidze EK; Voskanian NA; Kiunemund O; Knol' G
Vestn Akad Med Nauk SSSR; 1986; (3):66-8. PubMed ID: 3518270
[No Abstract] [Full Text] [Related]
37. Don't forget about Streptococcus pyogenes! (comment on Microbes Infect. 5 (2003) 1329-1335).
Collin M
Microbes Infect; 2004 Mar; 6(3):336; author reply 337. PubMed ID: 15026018
[No Abstract] [Full Text] [Related]
38. [Streptococcal infection and rheumatic fever (author's transl)].
Hernández RodrÃguez M
An Esp Pediatr; 1981 Aug; 15(2):139-50. PubMed ID: 7034609
[TBL] [Abstract][Full Text] [Related]
39. Cutting edge issues in rheumatic fever.
Chang C
Clin Rev Allergy Immunol; 2012 Apr; 42(2):213-37. PubMed ID: 21597903
[TBL] [Abstract][Full Text] [Related]
40. [Rheumatic fever].
Fujikawa S
Ryoikibetsu Shokogun Shirizu; 2000; (31):454-7. PubMed ID: 11269134
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
